Treatment options for leishmaniasis
Date issued
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
License
Abstract
Leishmaniasis is broadly classified into three types: cutaneous, mucocutaneous and visceral. The visceral form is most dangerous and can result in death. Although leishmaniasis is an ancient disease, its treatment is still challenging. Several drugs, differing in their cost, toxicity, treatment duration and emergence of drug resistance, are used for different types of leishmaniasis. To overcome these limitations, the search for newer drugs and other treatments continues. In this article, we discuss conventional drugs, other treatments, including newer options such as immunotherapy and immunochemotherapy, and future prospects for leishmaniasis treatment.
Description
Keywords
Citation
Published in
Clinical and experimental dermatology, 47, 3, Wiley-Blackwell, Oxford u.a, 2022, https://doi.org/10.1111/ced.14919